Skip to main content
Premium Trial:

Request an Annual Quote

OncoMethylome Sciences Discloses Plans for $44.2M European IPO

NEW YORK, June 9 (GenomeWeb News) - Belgian pharmacogenomics and molecular diagnostics company OncoMethylome Sciences today disclosed details about its planned initial public offering in Europe.


The company hopes the IPO will raise around 35 million ($44.2 million), which may be increased by 15 percent to cover any over-allotments. The price of each share is set at between 7.50 and 10. The offer period is expected to begin on June 12 and close on June 23.


Euronext Brussels and Euronext Amsterdam will list the shares on Eurolist under the symbol ONCO beginning June 27.


OncoMethylome plans to use the funds to support its growth, to increase its capitalization and financial flexibility, and to increase R&D activities. The cash will also be used for working capital and other general corporate purposes, the company said.


The shares will be offered to retail investors in Belgium and The Netherlands and to European institutional investors. The sales prospectus will be available tomorrow.


Fortis and ING have been appointed as joint bookrunners and joint lead managers, with Kempen & Co. as co-manager.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.